CERA - Cera Sanitaryware Ltd. Share Price

Cera Sanitaryware Limited's management provided an optimistic outlook during the Q3 FY '26 earnings call. They reported a healthy top-line growth of 11.1% for the quarter, following a sequential recovery in the previous quarter with a growth of 5% to 6%. This indicates a structural improvement in demand conditions, driven by a residential upcycle in the real estate sector and a recovery in rural demand. The management anticipates that this growth trajectory will remain sustainable in the near term, supported by continued operational focus.

Key forward-looking points highlighted by management include:

1. Demand Recovery: The real estate sector is seeing increased premiumization, which is driving demand for higher-value building products. Early signs of improvement in demand for both Faucetware and Sanitaryware were noted.

2. Strategic Initiatives: Management emphasized strengthening brand positioning and channel strategies. They are focusing on ongoing projects like Senator and POLIPLUZ, with 32 operational Senator stores and robust distribution through 65 distributors and 750 dealers for POLIPLUZ.

3. Capacity Utilization: While capacity utilization was at 102% for Faucetware and 82% for Sanitaryware, the firm is focused on disciplined cost management and operational efficiency to protect margins amid input pressures.

4. Future Growth: Management is confident about returning to EBITDA margins of 13-14% in Q4 FY "˜26, and aiming for 15-16% margins eventually, driven by increased sales and operational efficiencies.

5. Market Sentiment: The company expects supportive border policy measures for consumption will boost housing activity sentiment and that their established brands and distribution networks will further aid this growth.

Overall, a cautious yet confident tone reflects management's preparedness to navigate the market's challenges while capturing growth opportunities as demand conditions improve.

Major Questions and Answers from the Q&A Section

Question 1: "Could you confirm if the 300-basis point drop in EBITDA margin is largely due to the brass price increase in Faucetware?"

Answer 1: Yes, the EBITDA margin drop of 3% was primarily driven by increased trade discounts related to our project participation, which rose by 12% year-on-year. Additionally, the cost of goods sold saw an increase due to brass prices rising approximately 12%, affecting manufacturing and procurement. We did experience additional publicity spends and preoperative costs related to Senator. To address margin pressure, we announced calibrated price increases in both Faucetware and Sanitaryware.

Question 2: "What has changed in the last few months to result in a drop to a 10% EBITDA margin, particularly given previous guidance of 14% to 15%?"

Answer 2: The 10% margin for Q3 is not expected to be the trend going forward. We typically see higher margins, and we anticipate returning to the 13%-14% range in Q4. Q3 saw higher costs due to phased publicity expenditures and higher CSR activities. As sales ramp up from initiatives like Senator and POLIPLUZ, we expect margin recovery. It's essential to avoid extrapolating Q3 results too broadly; it was a one-off situation.

Question 3: "Can you elaborate on the stagnant sales growth over the past few years despite the positive real estate market conditions?"

Answer 3: Historically, we've faced stagnancy, especially over the last two years. However, we observed a growth uptick in Q3 with an 11.1% increase and anticipate maintaining that momentum in Q4. Our long-term goal remains a revenue growth target of approximately 7%-8% for the fiscal year, driven by improved market conditions and our strategic initiatives.

Question 4: "Was the growth this quarter due to pre-buying ahead of the price hikes, or was there an actual demand improvement?"

Answer 4: The growth in Q3 was fundamentally driven by actual improvement in demand, not merely pre-buying. We only announced the price increase in Q4, and prior to that, Q3 growth was based on genuine market revitalization and strategic initiatives rolled out by the company.

Question 5: "What was the amount spent on publicity and costs associated with Senator and POLIPLUZ during Q3, and how do these figures compare to last year?"

Answer 5: In Q3, the publicity spend was INR 17.27 crore, up from INR 13.87 crore the previous year"”an increase of around INR 3.5 to INR 4 crore. For Senator and POLIPLUZ, we spent approximately INR 6 crore in Q3 alone, including salaries and promotional expenses, while the total for the first nine months reached INR 35.58 crore, compared to INR 40.89 crore last year.

Question 6: "What are the price hikes for Sanitaryware and Faucetware announced, and is that sufficient to cover cost increases?"

Answer 6: The price increase we communicated is approximately 4% for Sanitaryware and 11% for Faucetware. This increase is designed to address the cost pressures we've experienced, specifically from brass prices, which have seen substantial rises. We believe these adjustments will sufficiently cover the increased costs we've faced to date.

Question 7: "What is the plan for the new Sanitaryware facility, and what is the current status?"

Answer 7: We have acquired the land for the new facility; however, we have not yet started construction. We plan to review the market situation at the end of Q4 to determine if we can proceed. Our current production capabilities have improved significantly, so we're evaluating operational efficiency before committing to new capital expenditures.

These questions help clarify the company's current operational outlook and strategic direction amid recent challenges.